Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2020.05.012
Abstract: Highlights • We evaluated the effect of the second-generation TRAIL receptor agonist APG-880 on radiation-induced cytotoxicity.• The combined effect was studied in short-term and long-term cytotoxicity assays in established CRC cell lines, and tumor organoids…
read more here.
Keywords:
receptor agonist;
trail receptor;
effect;
second generation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-75288-y
Abstract: Dipeptidyl peptidase-4 inhibitors (DPP4i) are antidiabetic medications that prevent cleavage of incretin hormones by dipeptidyl peptidase-4 (DPP4). DPP4 is ubiquitously expressed, and its hepatic DPP4 expression is upregulated under non-alcoholic steatohepatitis (NASH) conditions. We investigated…
read more here.
Keywords:
trail receptor;
peptidase;
expression;
mice ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biochemistry (Moscow)"
DOI: 10.1134/s0006297919060051
Abstract: The cytokine TRAIL induces apoptosis in tumor cells of various origin without affecting normal cells. Clinical trials of TRAIL-receptor (DR4 and DR5) agonists (recombinant TRAIL or death receptors antibodies) have largely failed because most human…
read more here.
Keywords:
efficient method;
cytokine trail;
dr5;
trail ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2019.01530
Abstract: Tumor necrosis factor (TNF) related apoptosis-inducing ligand (TRAIL) signaling is far more complex than initially anticipated and can lead to either anti- or protumorigenic effects, hampering the successful clinical use of therapeutic TRAIL receptor agonists.…
read more here.
Keywords:
trail signaling;
trail;
trail receptor;
tumor microenvironment ... See more keywords